Using AI to create better, more potent medicines

Novel framework could offer chemists greater drug options

2023-05-30

(Press-News.org) COLUMBUS, Ohio – While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process.

Today, most drug discovery is carried out by human chemists who rely on their knowledge and experience to select and synthesize the right molecules needed to become the safe and efficient medicines we depend on. To identify the synthesis paths, scientists often employ a technique called retrosynthesis – a method for creating potential drugs by working backward from the wanted molecules and searching for chemical reactions to make them.

Yet because sifting through millions of potential chemical reactions can be an extremely challenging and time-consuming endeavor, researchers at The Ohio State University have created an AI framework called G2Retro to automatically generate reactions for any given molecule. The new study showed that compared to current manual-planning methods, the framework was able to cover an enormous range of possible chemical reactions as well as accurately and quickly discern which reactions might work best to create a given drug molecule.

“Using AI for things critical to saving human lives, such as medicine, is what we really want to focus on,” said Xia Ning, lead author of the study and an associate professor of computer science and engineering at Ohio State. “Our aim was to use AI to accelerate the drug design process, and we found that it not only saves researchers time and money but provides drug candidates that may have much better properties than any molecules that exist in nature.”

This study builds on previous research of Ning’s where her team developed a method named Modof that was able to generate molecule structures that exhibited desired properties better than any existing molecules. “Now the question becomes how to make such generated molecules, and that is where this new study shines,” said Ning, also an associate professor of biomedical informatics in the College of Medicine.

The study was published today in the journal Communications Chemistry.

Ning’s team trained G2Retro on a dataset that contains 40,000 chemical reactions collected between 1976 and 2016. The framework “learns” from graph-based representations of given molecules, and uses deep neural networks to generate possible reactant structures that could be used to synthesize them. Its generative power is so impressive that, according to Ning, once given a molecule, G2Retro could come up with hundreds of new reaction predictions in only a few minutes.

“Our generative AI method G2Retro is able to supply multiple different synthesis routes and options, as well as a way to rank different options for each molecule,” said Ning. “This is not going to replace current lab-based experiments, but it will offer more and better drug options so experiments can be prioritized and focused much faster.”

To further test the AI’s effectiveness, Ning’s team conducted a case study to see if G2Retro could accurately predict four newly released drugs already in circulation: Mitapivat, a medication used to treat hemolytic anemia; Tapinarof, which is used to treat various skin diseases; Mavacamten, a drug to treat systemic heart failure; and Oteseconazole, used to treat fungal infections in females. G2Retro was able to correctly generate exactly the same patented synthesis routes for these medicines, and provided alternative synthesis routes that are also feasible and synthetically useful, Ning said.

Having such a dynamic and effective device at scientists’ disposal could enable the industry to manufacture stronger drugs at a quicker pace – but despite the edge AI might give scientists inside the lab, Ning emphasizes the medicines G2Retro or any generative AI creates still need to be validated – a process that involves the created molecules being tested in animal models and later in human trials.

“We are very excited about generative AI for medicine, and we are dedicated to using AI responsibly to improve human health,” said Ning.

This research was supported by Ohio State’s President’s Research Excellence Program and the National Science Foundation. Other Ohio State co-authors were Ziqi Chen, Oluwatosin Ayinde, James Fuchs and Huan Sun.

#

Contact: Xia Ning, Ning.104@osu.edu

Written by: Tatyana Woodall, Woodall.52@osu.edu

END

ELSE PRESS RELEASES FROM THIS DATE:

Quest for alien signals in the heart of the Milky Way takes off

2023-05-30

May 30, 2023, Mountain View, CA – Akshay Suresh, a graduate student at Cornell University, spearheads an extraordinary scientific endeavor -- a groundbreaking mission to uncover periodic signals emanating from the core of the Milky Way called the Breakthrough Listen Investigation for Periodic Spectral Signals (BLIPSS). Such repetitive patterns could be the key to unlocking the mysteries of extraterrestrial intelligence in our galaxy. Suresh and his co-authors detail the project’s results thus far in a paper accepted for publication in the Astronomical Journal, “A 4–8 GHz Galactic Center Search for Periodic Technosignatures.” BLIPSS ...

Deconstructing the role of MALAT1 in MAPK-Signaling in melanoma

2023-05-30

“In this study, we present novel transcriptional dependencies between MALAT1 and MAPK-pathway-associated genes in melanoma.” BUFFALO, NY- May 30, 2023 – A new research paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, “Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment.” The long non-coding RNA (lncRNA) MALAT1 is a regulator of oncogenesis and cancer progression. MAPK-pathway upregulation is the main event in the development and progression of human cancer, including melanoma and recent studies have shown that MALAT1 has a significant impact on the ...

Obstructive sleep apnea disrupts gene activity throughout the day in mice

2023-05-30

The low blood oxygen levels of obstructive sleep apnea cause widespread changes in gene activity throughout the day, according to a new study in the open-access journal PLOS Biology by David Smith of Cincinnati Children’s Hospital Medical Center, US, and colleagues. The finding may lead to tools for earlier diagnosis and tracking of the disorder. Obstructive sleep apnea (OSA) occurs when the airway becomes blocked (usually by soft tissue, associated with snoring and interrupted breathing during the night), resulting in intermittent hypoxia (low blood oxygen) and disrupted sleep. ...

Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine

2023-05-30

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO). Currently, the WHO reports more than 38 million people globally live with the retrovirus, and each year, another 1 million new cases are diagnosed. While antiretroviral therapy helps keep HIV in check, patients must stay on their medication to prevent the development of AIDS. Scientists have spent years trying to develop an ...

Researchers identify link between alternative gene splicing and risk of alcohol use disorder

2023-05-30

INDIANAPOLIS—Researchers at Indiana University School of Medicine have discovered alternative gene splicing, which occurs during gene expression, can impact a person’s risk of alcohol use disorder (AUD). They recently published their findings in Molecular Psychiatry. “AUD is a common and complex genetic disorder that happens people experience problems related to excessive alcohol consumption,” said Rudong Li, PhD, a postdoctoral fellow in the YunLong Liu, PhD Laboratory and lead author of the paper. “This discovery has revealed ...

Novel approach significantly improves access, decreases wait times for autism screening

2023-05-30

FOR IMMEDIATE RELEASE, May 30, 2023 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu Novel Approach Significantly Improves Access, Decreases Wait Times for Autism Screening Developmentally Trained-Primary Care Clinicians can reduce disparities for children referred for developmental evaluation (Boston)—Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social communication and the presence of repetitive and restricted behaviors or interests. The American Academy of Pediatrics (AAP) recommends autism-specific screening at 18- and 24-month well-child visits, yet earlier diagnosis has been shown to ...

Illinois professor examines lasting legacy of al-Andalus for Arabs, Muslims today

2023-05-30

CHAMPAIGN, Ill. — Before it was home to Spain and Portugal, much of the Iberian Peninsula was ruled by a succession of Islamic dynasties for almost 800 years during the Middle Ages. Known as al-Andalus, its influence is still reflected in art and politics today – not only in Spain and North Africa, but also in places far from the historical site of al-Andalus. Eric Calderwood, a comparative and world literature professor at the University of Illinois Urbana-Champaign, wrote about that influence and how it is used to make sense of the present in his new book, “On Earth or in Poems: ...

Astronomers discover planets in NASA Kepler's final days of observations

2023-05-30

A team of astrophysicists and citizen scientists have identified what may be some of the last planets NASA’s retired Kepler space telescope observed during its nearly decade-long mission. The trio of exoplanets – worlds beyond our solar system – are all between the size of Earth and Neptune and closely orbit their stars. ''These are fairly average planets in the grand scheme of Kepler observations,” said Elyse Incha, a senior at the University of Wisconsin-Madison. “But they’re exciting because Kepler observed them during its last few days of operations. It showcases just how good Kepler was at planet hunting, even at the end of its ...

Matthew Bailes, Duncan Lorimer and Maura McLaughlin receive the 2023 Shaw Prize in Astronomy

2023-05-30

The Shaw Prize in Astronomy 2023 is awarded in equal shares to Matthew Bailes, Director of the Australian Research Council (ARC) Centre of Excellence for Gravitational Wave Discovery, Duncan Lorimer, Professor and Interim Chair of Physics and Astronomy and Associate Dean for Research at Eberly College of Arts and Sciences at West Virginia University, USA and Maura McLaughlin, Eberly Family Distinguished Professor at the Department of Physics and Astronomy, West Virginia University, USA, for the discovery ...

Are pandemic lockdowns and vaccinations complements or substitutes? Lessons learned from COVID-19 should be considered in future pandemics

2023-05-30

Worldwide, one of the initial responses to the COVID-19 virus was locking down parts of the economy to reduce social interactions and the virus’s spread. Now, the development and production of vaccines have largely replaced broad lockdowns. In a new study that considered epidemiology and economics, researchers sought to determine how the arrival of vaccines should affect the duration and intensity of lockdown policies. They concluded that boosting the rate of vaccine use influences intensity and duration of lockdowns, depending on a variety of factors. The study was conducted by researchers at Carnegie Mellon University (CMU), the International Institute for Applied Systems Analysis, ...

Using AI to create better, more potent medicines

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: